$240 Million is the total value of OIKOS HOLDINGS LLC's 10 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 9.1% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
VXF | Sell | VANGUARD INDEX FDSextend mkt etf | $62,262,820 | -4.2% | 444,100 | -9.2% | 25.94% | -20.3% |
ITOT | Buy | ISHARES TRcore s&p ttl stk | $37,548,006 | +306.0% | 414,666 | +280.2% | 15.64% | +237.6% |
VOO | VANGUARD INDEX FDS | $37,426,862 | +7.0% | 99,521 | 0.0% | 15.59% | -11.0% | |
VTI | Buy | VANGUARD INDEX FDStotal stk mkt | $31,706,935 | +151.5% | 155,350 | +135.6% | 13.21% | +109.1% |
VNQ | Buy | VANGUARD INDEX FDSreal estate etf | $21,007,542 | +211.1% | 252,981 | +209.0% | 8.75% | +158.7% |
VXUS | Buy | VANGUARD STAR FDSvg tl intl stk f | $16,695,725 | +35.0% | 302,404 | +26.4% | 6.96% | +12.2% |
USRT | Sell | ISHARES TRcre u s reit etf | $13,388,861 | -22.8% | 265,652 | -24.2% | 5.58% | -35.8% |
SCHF | SCHWAB STRATEGIC TRintl eqty etf | $8,202,360 | +8.0% | 235,700 | 0.0% | 3.42% | -10.1% | |
VCSH | VANGUARD SCOTTSDALE FDSshrt trm corp bd | $7,050,894 | +1.4% | 92,495 | 0.0% | 2.94% | -15.7% | |
VEU | Buy | VANGUARD INTL EQUITY INDEX Fallwrld ex us | $4,759,418 | +39.6% | 89,011 | +30.9% | 1.98% | +16.1% |
IWM | Exit | ISHARES TRrussell 2000 etf | $0 | – | -134,300 | -100.0% | -11.73% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-04-27
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
VANGUARD INDEX FDS | 13 | Q3 2023 | 82.8% |
VANGUARD INDEX FDS | 11 | Q3 2023 | 42.2% |
VANGUARD STAR FDS | 10 | Q3 2023 | 32.6% |
VANGUARD SCOTTSDALE FDS | 9 | Q3 2023 | 7.4% |
ISHARES TR | 8 | Q3 2019 | 62.5% |
FGL HLDGS | 8 | Q3 2019 | 39.0% |
ISHARES TR | 8 | Q3 2023 | 16.0% |
VANGUARD INTL EQUITY INDEX F | 8 | Q3 2023 | 4.0% |
VANGUARD INDEX FDS | 7 | Q3 2023 | 13.7% |
MELINTA THERAPEUTICS INC | 5 | Q4 2018 | 64.1% |
View OIKOS HOLDINGS LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
MELINTA THERAPEUTICS, INC. /NEW/ | December 20, 2018 | 16,007,237 | 28.6% |
View OIKOS HOLDINGS LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-02 |
13F-HR | 2023-11-01 |
13F-HR | 2023-08-14 |
13F-HR | 2023-04-27 |
13F-HR | 2023-01-26 |
13F-HR | 2022-11-02 |
13F-HR | 2022-07-28 |
13F-HR | 2022-04-28 |
13F-HR | 2022-01-31 |
13F-HR | 2021-10-19 |
View OIKOS HOLDINGS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.